Armin Gamper is an Associate Professor in the Department of Oncology at the University of Alberta, specializing in Cancer Biology and DNA damage response. His research focuses on the mechanisms governing DNA damage signaling and its implications for cancer therapy. He aims to improve the understanding of cancer development and enhance therapeutic approaches, particularly through radiotherapy and chemotherapies. Dr. Gamper's lab, established in 2015, investigates the therapeutic potential of targeting DNA damage responses and the regulation of stemness in cancer cells under hypoxic conditions. The lab's current projects include studies on ionizing radiation-induced breast cancer cell plasticity, novel methods for identifying proteins at DNA damage sites, and developing non-invasive tools to assess tumor response to radiation. Dr. Gamper has assembled a multidisciplinary team to facilitate knowledge transfer from molecular findings to preclinical studies. He also emphasizes the importance of combining expertise from various scientific fields, including medicinal chemistry and biochemistry, to address complex cancer biology challenges. His dedication to education allows students and postdocs to participate actively in research initiatives conducted in his lab.